Clinical Trial

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

Study acronym: LYSARI
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to investigate the effect of ATRA (Vesanoid) and the effect of tailored radiotherapy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-22; most recent amendment 2026-04-21.
Status change: Not Yet Recruiting → Recruiting 2025-02-21
Trial Details
NCT Number NCT06706401
Lead Sponsor Centre Leon Berard
Conditions Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer, Primary Head and Neck Tumor
Enrollment 460 participants
Start Date 2025-02-20
Primary Completion 2029-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24